ES8700940A1 - Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus - Google Patents

Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus

Info

Publication number
ES8700940A1
ES8700940A1 ES549671A ES549671A ES8700940A1 ES 8700940 A1 ES8700940 A1 ES 8700940A1 ES 549671 A ES549671 A ES 549671A ES 549671 A ES549671 A ES 549671A ES 8700940 A1 ES8700940 A1 ES 8700940A1
Authority
ES
Spain
Prior art keywords
prevention
improvements relating
treatment control
rhinovirus infections
rhinovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES549671A
Other languages
English (en)
Other versions
ES549671A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TYRRELL DAVID ARTH
Original Assignee
TYRRELL DAVID ARTH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848430883A external-priority patent/GB8430883D0/en
Priority claimed from GB858511658A external-priority patent/GB8511658D0/en
Application filed by TYRRELL DAVID ARTH filed Critical TYRRELL DAVID ARTH
Publication of ES549671A0 publication Critical patent/ES549671A0/es
Publication of ES8700940A1 publication Critical patent/ES8700940A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE COMPOSICIONES PARA EL TRATAMIENTO DE INFECCIONES POR RINOVIRUS. SE HACE INTERACCIONAR SINERGICAMENTE UNA SUSTANCIA ANTIVIRAL NO INTERFERONICA, ACTIVA CONTRA EL RINOVIRUS, CON UN INTERFERON, PRODUCIENDOSE DICHA INTERACCION SINERGICA EN UN ENVASE QUE COMPRENDE DOS FASES PARA LA APLICACION ORAL O INTRANASAL, SIMULTANEA, SEPARADA O SECUENCIAL, ESTANDO DICHAS FASES AISLADAS UNA DE LA OTRA, COMPRENDIENDO UNA DE LAS FASES LA SUSTANCIA ANTIVIRAL NO INTERFERONICA, ACTIVA CONTRA EL RINOVIRUS, JUNTO CON UN VEHICULO, Y ESTANDO CONSTRUIDO EL RECIPIENTE DE MANERA QUE FACILITE Y FAVOREZCA LAS FORMAS E APLICACION SIMULTANEA, SEPARADA Y SECUENCIAL, Y APLIQUE UNA DOSIS SINERGICAMENTE EFICAZ. LAS COMPOSICIONES Y EL PROCEDIMIENTO DE ADMINISTRACION SON APLICACION PARA EL TRATAMIENTO O PREVENCION DE LAS INFECCIONES POR RINOVIRUS.
ES549671A 1984-12-06 1985-12-06 Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus Expired ES8700940A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848430883A GB8430883D0 (en) 1984-12-06 1984-12-06 Treatment/control of rhinoviruses
GB858511658A GB8511658D0 (en) 1985-05-08 1985-05-08 Treatment control/prevention of rhino-virus infection

Publications (2)

Publication Number Publication Date
ES549671A0 ES549671A0 (es) 1986-11-16
ES8700940A1 true ES8700940A1 (es) 1986-11-16

Family

ID=26288545

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549671A Expired ES8700940A1 (es) 1984-12-06 1985-12-06 Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus

Country Status (6)

Country Link
EP (1) EP0207116A1 (es)
AU (1) AU5234586A (es)
ES (1) ES8700940A1 (es)
GB (1) GB2168608A (es)
NO (1) NO863165D0 (es)
WO (1) WO1986003412A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820515A (en) * 1982-12-13 1989-04-11 Texas A&M University System Method of using interferon in low dosage to regulate appetite and efficiency of food utilization
US4820514A (en) * 1985-12-30 1989-04-11 Texas A&M University System Low dosage of interferon to enhance vaccine efficiency
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080032A3 (en) * 1981-11-20 1985-11-13 Enzo Biochem, Inc. Pharmaceutical preparation for treating herpetic lesions

Also Published As

Publication number Publication date
NO863165L (no) 1986-08-05
AU5234586A (en) 1986-07-01
NO863165D0 (no) 1986-08-05
EP0207116A1 (en) 1987-01-07
WO1986003412A1 (en) 1986-06-19
ES549671A0 (es) 1986-11-16
GB2168608A (en) 1986-06-25
GB8530152D0 (en) 1986-01-15

Similar Documents

Publication Publication Date Title
IT8522574A0 (it) Composizione farmaceutica eprocedimento per trattare il corpo umano con essa.
FR2615394B1 (fr) Utilisation de certains 17-cetosteroides, eventuellement avec un immunomodulateur et/ou un agent antiviral, pour fabriquer un medicament pour le traitement et la prevention des infections retrovirales
MY108638A (en) Antiviral nucleoside combination.
NZ309217A (en) Ribavirin and interferon alpha for the treatment of hepatitis C
ES2155834T3 (es) Procedimiento de tratamiento de lesiones o de disminuciones celulares.
GR3019514T3 (en) Pharmaceutical preparation for the treatment of prolonged coagulation time
ATE26216T1 (de) Zusammensetzungen mit gehalt an interferon und ihre therapeutische anwendung.
OA09917A (en) Compounds for use in treating HIV infection
EP0313654A4 (en) MEDICINE FOR PROPHYLAXIS AND TREATMENT OF HEPATOPATHY.
ES8700940A1 (es) Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus
DE3569673D1 (en) Use of saccharomyces yeasts for the manufacture of a medicament for preventing or treating pseudo-membranous colitis
ZA968783B (en) Flupirtine usage
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
FR2361109A1 (fr) Medicaments anthelminthiques
ZA963274B (en) Use of leukemia inhibitory factor and endothelin antagonists.
EP1240899A3 (en) Modulation of Th1/Th2 Cytokine expression by Ribavirin and Ribavirin analogs in actived T-Lymphocytes for treating HCV infections
EP0656116A4 (en) METHOD FOR MONITORING THE EFFECTIVENESS OF INTERFERON THERAPY ON HEPATITIS-C INFECTED INDIVIDURES.
ES2103811T3 (es) Terapia antiviral.
FI952018A0 (fi) BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskriptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon
JPS55113721A (en) Immunity regulator
EP1143981A4 (en) TREATMENT AND PREVENTION OF HIV AND OTHER VIRUS INFECTIONS
IL107818A0 (en) Method of treating viral infections by conjunctive therapy with acyclovir-like compounds and a 2'-vinyl substituted nucleoside analog
AU8353601A (en) Treatment of hepatitis c with thymosin, interferon and ribavirin
OA09771A (en) Asphodelus composition for increasing white blood cell count.
EP0278715A3 (en) Use of human gamma interferon for treatment of basal cell carcinoma